Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

NCT01799538 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

100

Enrollment

NIH

Sponsor class

Conditions

Lymphangioleiomyomatosis

Interventions

DRUG: albuterol inhaler
DRUG: albuterol nebulizer
PROCEDURE: PFT

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)